About
SensArs is a medtech company that specializes in neurostimulation technologies aimed at treating chronic neuropathic pain and restoring sensory feedback. Founded by experts in nerve interfacing and technology development, the company focuses on patients suffering from conditions like diabetic neuropathy and limb amputations. The core product, known as SENSY, is an implantable stimulator device that interacts with peripheral nerves to recreate natural touch and movement sensations. This innovative technology helps alleviate pain caused by nerve damage and enhances communication between nerve-damaged areas and the brain. SensArs has successfully conducted human clinical trials and has received breakthrough device designation, indicating its significant potential in healthcare. With a team of specialists in neuromodulation and clinical development, SensArs aims to benefit millions of patients worldwide who experience chronic neuropathic pain. The company has also secured funding to further advance its neuromodulation technology.
Technologies
Keywords
Company Information
- Employees8
- Founded2014
- Total Funding$3525601
Location
Lausanne, Vaud, Switzerland
